InsidersTradesSigma
John Hancock GA Senior Loan Trust: insider trades · United States · SEC (Form 4)
SEC:john-hancock-ga-senior-loan-trust-db703aUS·SEC (Form 4)Mcap 73M€Finance & Banking
Discover the full insider trade history of John Hancock GA Senior Loan Trust, a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Finance & Banking sector, John Hancock GA Senior Loan Trust has published 60 public disclosures. Market capitalisation: €72.6m. The latest transaction was reported on 16 May 2022 — Acquisition. Among the most active insiders: Manufacturers Life Reinsurance Ltd. The full history is accessible without an account.
60
Insider Decl.
0
Thresholds
€138m
60 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
Income statement
Revenue27.0 M€
Gross profit−39.8 M€-147% margin
Net income135.5 M€501.6% margin
Balance sheet & cash
Market cap72.6 M€
Total debt235.6 M€
Free Cash Flow−108.3 M€
Last declaration on 16 May 2022
Declarations60 total
Executives▲Purchase◆Signal · 47SEC
€4m282,649.88 shares@ €15.64026.09% mcap10.4% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000027:0·
Ideal exit: 7 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 46SEC
€2m157,356.321 shares@ €15.64023.39% mcap9.3% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000025:0·
Ideal exit: 7 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 47SEC
€6m414,271.803 shares@ €15.64028.93% mcap12.8% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000028:0·
Ideal exit: 7 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 45SEC
€2m115,139.723 shares@ €15.64022.48% mcap9.8% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000026:0·
Ideal exit: 7 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 48SEC
€5m308,240.162 shares@ €15.44196.56% mcap17.9% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000022:0·
Ideal exit: 24 Jan 2023 (T+270)
Executives▲Purchase◆Signal · 45SEC
€1m92,488.078 shares@ €15.44191.97% mcap7.8% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000023:0·
Ideal exit: 24 Jan 2023 (T+270)
Executives▲Purchase◆Signal · 47SEC
€3m215,752.085 shares@ €15.44194.59% mcap6.6% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000024:0·
Ideal exit: 24 Jan 2023 (T+270)
Executives▲Purchase40SEC
€382,80325,495.116 shares@ €15.01480.53% mcap1.4% of flow
common shares of beneficial interest
SEC:0001228616-22-000028:0·
Ideal exit: 13 Jan 2023 (T+270)
Executives▲Purchase40SEC
€305,11420,320.958 shares@ €15.01480.42% mcap1.7% of flow
common shares of beneficial interest
SEC:0001228616-22-000029:0·
Ideal exit: 13 Jan 2023 (T+270)
Executives▲Purchase42SEC
€791,68852,727.32 shares@ €15.01481.09% mcap1.9% of flow
common shares of beneficial interest
SEC:0001228616-22-000026:0·
Ideal exit: 13 Jan 2023 (T+270)
Executives▲Purchase43SEC
€1m74,579.716 shares@ €15.01481.54% mcap2.2% of flow
common shares of beneficial interest
SEC:0001228616-22-000027:0·
Ideal exit: 13 Jan 2023 (T+270)
Executives▲Purchase44SEC
€1m86,684.778 shares@ €14.58631.74% mcap6.9% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000020:0·
Ideal exit: 26 Dec 2022 (T+270)
Executives▲Purchase43SEC
€1m86,684.778 shares@ €14.58631.74% mcap2.5% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000021:0·
Ideal exit: 26 Dec 2022 (T+270)
Executives▲Purchase43SEC
€903,15261,917.699 shares@ €14.58631.24% mcap3.4% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000019:0·
Ideal exit: 26 Dec 2022 (T+270)
Executives▲Purchase42SEC
€796,85553,614.53 shares@ €14.86271.10% mcap1.9% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000015:0·
Ideal exit: 10 Dec 2022 (T+270)
Executives▲Purchase43SEC
€1m74,719.434 shares@ €14.86271.53% mcap2.2% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000016:0·
Ideal exit: 10 Dec 2022 (T+270)
Executives▲Purchase40SEC
€290,53119,547.695 shares@ €14.86270.40% mcap1.6% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000014:0·
Ideal exit: 10 Dec 2022 (T+270)
Executives▲Purchase40SEC
€373,46225,127.542 shares@ €14.86270.51% mcap1.4% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000013:0·
Ideal exit: 10 Dec 2022 (T+270)
Executives▲Purchase43SEC
€1m83,793.862 shares@ €14.37921.66% mcap4.5% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000009:0·
Ideal exit: 12 Nov 2022 (T+270)
Executives▲Purchase44SEC
€937,33065,186.516 shares@ €14.37921.29% mcap5.1% of flow
Common Shares of Beneficial Interest
SEC:0001839544-22-000010:0·
Ideal exit: 12 Nov 2022 (T+270)
Executives▲Purchase◆Signal · 46SEC
€3m178,790.61 shares@ €14.37923.54% mcap6.1% of flow
common shares of beneficial interest
SEC:0001228616-22-000024:0·
Ideal exit: 12 Nov 2022 (T+270)
Executives▲Purchase◆Signal · 47SEC
€4m249,170.015 shares@ €14.37924.94% mcap7.1% of flow
common shares of beneficial interest
SEC:0001228616-22-000025:0·
Ideal exit: 12 Nov 2022 (T+270)
Executives▲Purchase◆Signal · 46SEC
€2m121,576.16 shares@ €14.56652.44% mcap10.5% of flow
Common Shares of Beneficial Interest
SEC:0001839544-21-000036·
Ideal exit: 27 Aug 2022 (T+270)
Executives▲Purchase44SEC
€885,47060,788.08 shares@ €14.56651.22% mcap14.3% of flow
Common Shares of Beneficial Interest
SEC:0001839544-21-000035·
Ideal exit: 27 Aug 2022 (T+270)
Executives▲Purchase44SEC
€2m121,576.16 shares@ €14.56652.44% mcap4.2% of flow
Common Shares of Beneficial Interest
SEC:0001839544-21-000036:0·
Ideal exit: 27 Aug 2022 (T+270)
25 of 60 declarations
About John Hancock GA Senior Loan Trust
John Hancock GA Senior Loan Trust is a US-listed credit fund structured as a Delaware statutory trust and registered as a closed-end, non-diversified investment company under the Investment Company Act of 1940. It is part of the John Hancock / Manulife asset-management franchise, with principal executive offices at 197 Clarendon Street, Boston, Massachusetts 02116, United States. For French-, Belgian- and Swiss-based investors, this is best understood as exposure to the US leveraged-loan market rather than to a traditional operating company. The security is followed within the US listed-universe context on NYSE/NASDAQ, although recent SEC filings sometimes display the ticker as “N/A” in Form 4 and related regulatory documents. The fund’s investment objective is straightforward: to generate current income. Under normal market conditions, it invests at least 80% of net assets, plus any borrowings for investment purposes, in senior loans. Those loans include first-lien and second-lien term loans, delayed-draw term loans, and revolving credit facilities. The fund focuses on below-investment-grade borrowers, placing it in the higher-yield, higher-risk segment of the credit market. Its stated approach is generally buy-and-hold, with purchases made either at primary issuance or in the secondary market. From a competitive standpoint, John Hancock GA Senior Loan Trust participates in a crowded but specialized segment of credit funds, where vehicles seek floating-rate income and exposure to syndicated corporate lending. Its relative strengths are the John Hancock brand, the broader Manulife platform, and access to an asset class that is often more institutional in nature. For global investors, the fund can serve as a portfolio diversifier, but its performance will be highly sensitive to US credit conditions, borrower quality, default trends, and interest-rate dynamics. Recent SEC reporting shows continued filing activity in 2025, including an annual report for the year ended December 31, 2025 and a semi-annual report for the period ended June 30, 2025. The filings also disclose that John Hancock GA Senior Loan Subsidiary Trust LLC was incorporated on October 10, 2024, as a wholly owned subsidiary used within the fund structure. In addition, recent Form 4 disclosures point to insider/affiliate transaction reporting within the trust’s regulatory perimeter, underscoring the compliance-heavy nature of a US registered fund operating in the United States.
